Nebraska Advances Medical Cannabis Regulations Amid Public Concerns
The Nebraska Medical Cannabis Commission recently convened for its first meeting since Governor Jim Pillen approved the newly updated permanent regulations. As part of the updates, the commission has introduced fees for various cannabis-related businesses and established a framework to monitor cannabis products and outline requirements for transporters of medical cannabis. Despite these advancements, Commission Chairwoman Lorelle Meuting emphasized the need for further groundwork before the program’s implementation.
“Building a new regulatory agency is much like constructing a house,” Meuting stated. “Before patients can receive services, the commission must first build the foundation.”
Businesses aiming to enter Nebraska’s cannabis market must pay a $5,000 application fee. Additional fees are set at $20,000 for cultivators and manufacturers, $15,000 for dispensaries, and $10,000 for transporters. Renewing these licenses annually involves even higher costs. Current licensees are also required to participate in the state’s inventory tracking system by February 1, incurring a $13,000 fee.
Legal review of these regulations will be conducted by the commission’s attorney.
Although the Cannabis Commission has been operational for over a year, it has faced criticism from public commenters for delays in launching the medical cannabis program. The commission only gained necessary powers, such as hiring staff and collecting fees, after legislative changes in April.
During the meeting, updates were provided by current license holders, including Kent Rogert from KRL Med LLC. Rogert addressed past suspensions related to agricultural permits in Washington County, expressing optimism about clearing the issues and preparing for an inspection by the commission’s next meeting on August 17.
The commission also extended the deadline for manufacturing applications from July 20 to August 17 due to insufficient submissions. Present at the meeting were two manufacturers, Ogre Village and Sweetwater Cannabis Company, who queried about their submitted applications and provided hard copies.
Crista Eggers, Executive Director of Nebraskans for Medical Marijuana, urged the commission to consider protections for medical practitioners who are hesitant to prescribe cannabis due to potential legal repercussions. She challenged the commission to accelerate the program’s initiation.
“There is a widespread belief that this commission, which is responsible for implementing this program, does not want it to succeed,” Eggers remarked. “Choosing not to spearhead this is going to continue to support this narrative.”
